- Home
- TRDA vs RERE Comparison
TRDA vs RERE Comparison
Compare TRDA & RERE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRDA
- RERE
- Stock Information
- Founded
- TRDA 2016
- RERE 2011
- Country
- TRDA United States
- RERE China
- Employees
- TRDA N/A
- RERE N/A
- Industry
- TRDA Biotechnology: Pharmaceutical Preparations
- RERE Other Specialty Stores
- Sector
- TRDA Health Care
- RERE Consumer Discretionary
- Exchange
- TRDA Nasdaq
- RERE Nasdaq
- Market Cap
- TRDA 609.7M
- RERE 527.7M
- IPO Year
- TRDA 2021
- RERE 2021
- Fundamental
- Price
- TRDA $18.70
- RERE $2.96
- Analyst Decision
- TRDA Strong Buy
- RERE
- Analyst Count
- TRDA 3
- RERE 0
- Target Price
- TRDA $23.33
- RERE N/A
- AVG Volume (30 Days)
- TRDA 105.0K
- RERE 1.9M
- Earning Date
- TRDA 11-05-2024
- RERE 11-20-2024
- Dividend Yield
- TRDA N/A
- RERE N/A
- EPS Growth
- TRDA N/A
- RERE N/A
- EPS
- TRDA 1.55
- RERE N/A
- Revenue
- TRDA $215,232,000.00
- RERE $2,188,701,829.00
- Revenue This Year
- TRDA $47.45
- RERE $28.08
- Revenue Next Year
- TRDA N/A
- RERE $25.05
- P/E Ratio
- TRDA $11.61
- RERE N/A
- Revenue Growth
- TRDA 146.92
- RERE 27.16
- 52 Week Low
- TRDA $11.35
- RERE $1.01
- 52 Week High
- TRDA $21.79
- RERE $3.70
- Technical
- Relative Strength Index (RSI)
- TRDA 48.30
- RERE 50.85
- Support Level
- TRDA $17.26
- RERE $2.92
- Resistance Level
- TRDA $21.79
- RERE $3.15
- Average True Range (ATR)
- TRDA 0.88
- RERE 0.20
- MACD
- TRDA -0.29
- RERE -0.05
- Stochastic Oscillator
- TRDA 34.03
- RERE 20.22
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
About RERE ATRenew Inc.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform. The Company's principal operations and geographic markets are in the People's Republic of China.